| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 2.662 | 4.548 | 3.806 | 21.846 |
| Total Income - EUR | - | - | - | - | - | - | 2.662 | 4.548 | 3.806 | 21.846 |
| Total Expenses - EUR | - | - | - | - | - | - | 815 | 684 | 1.287 | 15.724 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.848 | 3.864 | 2.520 | 6.122 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.769 | 3.734 | 2.295 | 5.174 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Alvomed Grup S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 2.369 |
| Current Assets | - | - | - | - | - | - | 1.888 | 6.381 | 8.107 | 5.758 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 782 | 4.013 | 3.099 | 3.503 |
| Cash | - | - | - | - | - | - | 1.106 | 2.368 | 5.009 | 2.255 |
| Shareholders Funds | - | - | - | - | - | - | 1.810 | 5.550 | 7.828 | 7.058 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 78 | 832 | 279 | 1.068 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Alvomed Grup S.r.l.